The authors thank village chiefs, leaders and families of Dogo and Takieta villages,
the mothers of the children who participated in the study, and the ALIMA and BEFEN
teams for their enthusiasm, help and support without which this study could not have
taken place.


The study was funded in part by the Alliance for International Medical Action (ALIMA),
UNICEF, The Humanitarian Aid and Civil Protection Department of the European Commission
(ECHO), and the USAID Office of U.S. Foreign Disaster Assistance (OFDA).

Availability of data and materials

The Alliance for International Medical Action (ALIMA) and its field partners have
an open data sharing policy. (As an example of putting this policy in action, all
data from ALIMA’s treatment of patients confirmed with Ebola Virus Disease has been
shared with the Ebola Data Sharing Platform, of which ALIMA is a Steering Committee
member.) ALIMA will provide raw data that maintains participant confidentiality from
this study to interested researchers upon request. To make a request, please send
a written expression of interest to Kevin Phelan ([email protected]) that includes
the researcher’s ethical policy, a list of previous published or unpublished work,
and the main research question the data would be helpful in addressing.

Authors’ contributions

The study was conceived and designed by NB, ID, TAD, GH, GLD, FGBA, HI, ABr, NO, IY;
the study was performed by FGBA, HI, SSa; KI, ID, GLD, GH, NB, IY; the data were analyzed
by FGBA, MM, KPQP, GH, SSh, NB, ABr; the manuscript was written and edited by KPQP,
FGBA, MM, HI, ID, GLD, GH, SSa, KI, ABr SSh, TAD, NB, NO, IY. All authors read and
approved the final manuscript.

Authors’ information

FGBA, KPQP, HI, KI, GH, ID, GLD, TAD, SSh: Alliance for International Medical Action
(ALIMA), Dakar, Senegal. SSa: Bien Etre de la Femme et de l’Enfant au Niger (BEFEN),
Niamey, Niger. MM: Brixton Health, Llawryglyn, Wales, UK. ABr: Department of International
Health, University of Tampere School of Medicine, Tampere, Finland and Department
of Nutrition, Exercise and Sports, Faculty of Science, University of Copenhagen, Denmark.
NB: Alliance for International Medical Action, ALIMA Dakar, Senegal, and Department
of Critical Care, University of Queensland, Brisbane, Australia. NO, IY: Ministry
of Health, Niamey, Niger.

Competing interests

The authors have no conflict of interest to declare.

Consent for publication

Not applicable.

Ethics approval and consent to participate

This pragmatic interventional, non-randomized efficacy study was conducted according
to the guidelines laid down in the Declaration of Helsinki. The study protocol was
given ethical approval by the National Consultative Ethics Committee of Niger’s Ministry
of Public Health on April 10, 2013 (Deliberation Number 006/2013/CCNE.) Written informed
consent was obtained from all mothers or heads of households. The trial is registered
with (Trial number NCT01863394).